We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
12.50 | 0.76% | 1,653.00 | 1,654.00 | 1,655.00 | 1,655.50 | 1,634.00 | 1,638.50 | 3,990,601 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.83 | 68.14B |
Date | Subject | Author | Discuss |
---|---|---|---|
09/7/2021 14:49 | Thanks for that additional info net. Will have a look too. | lovewinshatelosses | |
09/7/2021 14:26 | I like m&s food. Cheaper than waitrose, and always without exception really good quality. Best value food imo, although obviously more expensive than lidl etc. So it's worth investing in is it net? May take a look. | pierre oreilly | |
09/7/2021 13:42 | Okay thanks Sue58 | abdullla | |
09/7/2021 13:41 | lovewinshatelosses: M&S has great NAV value. It has updated its clothing range to include some pretty good brand names (Jaeger - blimy that is right). or white stuff: or Hobbs or Sea Salt Cornwall: They are at every service station and more people are going by car to work to avoid public transport. With GAP closing and no Debenhams they have the advantage of being LAST MAN STANDING takes it all. They also have good in-store tea rooms which means the old love shopping there. Its price is at a historic low-ish side. It used to be a big FTSE100 company. I can see it either recovering or being taken over. Either way I think its good as Glaxo in its own way. Cheers NEt | netcurtains | |
09/7/2021 13:29 | Correct. 19p, 19p, 23p. | alex1621 | |
09/7/2021 13:23 | Abdullla - I think there is a dividend next February as well before the dividend decrease in May next year? | sue58 | |
09/7/2021 13:00 | jubberjim: Based on your criteria, maybe have a look at National Grid too. Not investment advice of course, etc. Interesting you like M&S as a share - I like their food range (even if it is not particularly good price value, IMO!), but as a business, especially right now, I think their best hope from a shareholder position, is a take out - which may of course be why you and your fellow holders there like it! Always thought the clothing side of the business let them down. High pension liabilities too, I presume. | lovewinshatelosses | |
09/7/2021 12:38 | Two more divis of 19p each yet to come | abdullla | |
09/7/2021 12:36 | jubberjim: You are a bit like me. I also like M&S. | netcurtains | |
09/7/2021 12:15 | Have just bought in for a safe dividend paying share only 30000 grand but am quite long of cash at moment Sold all my other holdings mostly financial as going nowhere fast due to the uncertainty generally in the broader markets This and bt.a my only significant holdings but will be looking to diversify so any reputable suggestions most welcome Otherwise happy to keep long f cash until I can see more clarity God luck everyone be lucky | jubberjim | |
09/7/2021 09:57 | Ftse up 55 points GSK now going into red rest of the markets going higher after yesterday's falls,not good. | abdullla | |
09/7/2021 09:49 | GSK announced recently a drug that was effective after you get Covid, it never really moved the needle. It just sounds like one of many ... it's not like Viagra or an HIV cure. | alex1621 | |
09/7/2021 09:41 | I've seen the results of late-stage Clinical Trials. The vaccine has shown safety and efficacy in a late-stage trial with more than 28,000 volunteers. | tradermichael | |
09/7/2021 09:31 | How do you know the Indian product is effective? The only pharma that comes out of India is off patent copycats, they are seldom in front of the curve on anything. | alex1621 | |
09/7/2021 08:37 | Zydus (India) about to launch a needle-free covid vaccine using novel plasmid DNA technology. GSK seem to be a long way behind the curve on researching and producing innovative vaccines in this field. The ZyCoV-D vaccine is the first ever plasmid DNA vaccine for human use and represents a key milestone in scientific innovation and technology advancement. It is delivered intradermally using the PharmaJet Tropis Needle-free Injection System, which enables enhanced vaccine effectiveness in addition to being highly preferred by patients and providers over other delivery methods. The DNA platform is ideally suited for a COVID-19 vaccine as it can be easily adapted to deal with mutations in the virus and has greater thermostability and less restrictive cold chain requirements compared with other vaccines. | tradermichael | |
08/7/2021 18:17 | An omen for the bid price at some point (1,710.40) - 4:30pm. Nice! 08-Jul-21 16:30:25 1,423.98 360,630 Buy* 1,710.40 1,282.60 5m O | netcurtains | |
08/7/2021 17:07 | interestingly "monkey with a pin" is about the only person making money on the stockchallenge: | netcurtains | |
08/7/2021 15:34 | I've learned simply to ignore them. Good or bad. | alex1621 | |
08/7/2021 15:16 | Exactly! I've learnt the hard way that Broker Buy Recs are contrarian indicators. spud | spud | |
08/7/2021 15:13 | Goldman goes bullish,ramps up target price. That's a SELL signal right there. because that is what they/their top clients will be doing. Selling into strength as mug punters buy. | geckotheglorious | |
08/7/2021 15:12 | Press one down and another pops up. Lol | mcflies | |
08/7/2021 14:45 | Battern down the hatches, Dow and FTSE 100 I reckon due for overdue correction, only 15%. | montyhedge | |
08/7/2021 13:57 | I thought everyone had VW man filtered?Must be of a masochistic bent if not...spud | spud |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions